How And Why We Decided To Bring "Pathways" To Market

At Medable, we’re always looking to understand the changing environment of clinical research, and how we can help clients overcome the various challenges, risks, and scenarios that these changes bring.

For the past year, I, various clinicians, and research experts at Medable have been working closely to improve the ways in which we conduct research for a variety of therapeutic areas. Much like the results shown in Tufts CSDD’s latest whitepaper, we believe that a well thought, decentralized approach can help bring new therapies in historically challenging therapeutic areas to markets faster.